4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-16-156270
CIK 0001382911operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 12:11 PM ET
Size
4.6 KB
Accession
0001209191-16-156270
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2016-12-19$1.96/sh−800$1,568→ 0 total
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 12:11 PM ET
- Size
- 4.6 KB